# Cellanome

> Cellanome makes the R3200, a research platform that cultures and films individual living cells or defined groups inside programmable CellCage enclosures, then links their observed behavior to molecular measurements from those same cells. Researchers can run the instrument in their labs or access assays through service providers and Cellanome services.

- **Founded:** 2020
- **Headquarters:** Foster City, United States
- **Founders:** Mostafa Ronaghi (Cofounder, executive board member)
- **Products:** Cellanome R3200 platform, CellCage enclosures, Cellanome Cloud, Assay services
- **Notable:** Began broad commercialization of the R3200 in the first quarter of 2026, according to Cellanome., Psomagen added the R3200 to its service lab in March 2026., Published May and August 2026 bioRxiv preprints on linked imaging/transcriptomics and CAR-T cell interactions.

## Products & services

- **Cellanome R3200 platform** — Automated instrument for culture, reagent delivery, live-cell imaging and RNA capture, used with flow cells, assays and cloud analysis.
- **CellCage enclosures** — Programmable, permeable micro-3D-printed enclosures that hold single cells or defined groups during longitudinal experiments.
- **Cellanome Cloud** — Software for experiment planning, run monitoring, visualization and linked imaging and sequencing analysis.
- **Assay services** — Experiments and paired imaging/transcriptomic datasets run through Cellanome or service partners.

## Achievements

- Began broad commercialization of the R3200 in the first quarter of 2026, according to Cellanome.
- Psomagen added the R3200 to its service lab in March 2026.
- Published May and August 2026 bioRxiv preprints on linked imaging/transcriptomics and CAR-T cell interactions.

## Latest updates

- **2026-08** — Cellanome and academic collaborators posted a CAR-T interaction preprint.
- **2026-07** — Psomagen opened a Cellanome research grant program for US academic, nonprofit and biopharma researchers.
- **2026-06** — Cellanome filed a securities notice reporting $75.93 million sold in an offering.
- **2026-05** — Cellanome researchers posted preprints on paired longitudinal imaging and transcriptomics.
- **2026-03** — Psomagen announced it had added the R3200 to its single-cell service portfolio.

## Links

- Website: https://www.cellanome.com/
- LinkedIn: https://www.linkedin.com/company/cellanome
- Twitter/X: https://x.com/cellanome
- Bluesky: https://bsky.app/profile/cellanome.bsky.social

---

Profile page: https://yespress.io/cellanome
Published by YesPress — https://yespress.io
Last updated: 2026-09-30